Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3555)
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
6,693
Price
$16.08
Total Value
$107.63K
Shares Held After
451,815
% of Holdings
1.5%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,931
Price
$60.72
Total Value
$481.57K
Shares Held After
391,673
% of Holdings
2.0%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
2,907
Price
$60.72
Total Value
$176.51K
Shares Held After
138,629
% of Holdings
2.1%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,582
Price
$60.72
Total Value
$156.78K
Shares Held After
47,858
% of Holdings
5.1%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.03
Total Value
$951.47K
Shares Held After
964,161
% of Holdings
4.9%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,287
Price
$182.94
Total Value
$235.44K
Shares Held After
6,512
% of Holdings
16.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
101,409
Price
$30.29
Total Value
$3.07M
Shares Held After
69,302
% of Holdings
59.4%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
2,161
Price
$200.76
Total Value
$433.84K
Shares Held After
30,724
% of Holdings
6.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$484.27
Total Value
$77.48K
Shares Held After
130
% of Holdings
55.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
450
Price
$483.69
Total Value
$217.66K
Shares Held After
290
% of Holdings
60.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$482.74
Total Value
$96.55K
Shares Held After
740
% of Holdings
21.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$481.59
Total Value
$115.58K
Shares Held After
940
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
938
Price
$480.47
Total Value
$450.68K
Shares Held After
1,180
% of Holdings
44.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
582
Price
$479.63
Total Value
$279.14K
Shares Held After
2,118
% of Holdings
21.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,212
Price
$478.32
Total Value
$579.72K
Shares Held After
2,700
% of Holdings
31.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,194
Price
$477.53
Total Value
$1.05M
Shares Held After
3,912
% of Holdings
35.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$476.37
Total Value
$419.20K
Shares Held After
6,106
% of Holdings
12.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,118
Price
$475.36
Total Value
$531.45K
Shares Held After
6,986
% of Holdings
13.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,001
Price
$474.12
Total Value
$474.60K
Shares Held After
8,104
% of Holdings
11.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
241
Price
$473.23
Total Value
$114.05K
Shares Held After
9,105
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
284
Price
$471.96
Total Value
$134.04K
Shares Held After
9,346
% of Holdings
2.9%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
400
Price
$100.19
Total Value
$40.08K
Shares Held After
324,879
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
16,015
Price
$99.29
Total Value
$1.59M
Shares Held After
325,279
% of Holdings
4.7%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
13,585
Price
$98.59
Total Value
$1.34M
Shares Held After
341,294
% of Holdings
3.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
2,090
Price
$3.26
Total Value
$6.81K
Shares Held After
173,999
% of Holdings
1.2%
NewAmsterdam Pharma Co N.V. (NAMS)
LANGE LOUIS G — Director
Shares
28,186
Price
$29.41
Total Value
$828.95K
Shares Held After
0
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$15.14
Total Value
$468.45K
Shares Held After
652,147
% of Holdings
4.5%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
10,000
Price
$29.58
Total Value
$295.84K
Shares Held After
51,000
% of Holdings
16.4%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
6,018
Price
$21.40
Total Value
$128.79K
Shares Held After
70,328
% of Holdings
7.9%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
3,000
Price
$15.06
Total Value
$45.18K
Shares Held After
11,500
% of Holdings
26.1%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.42
Total Value
$970.94K
Shares Held After
964,161
% of Holdings
4.9%
Lyell Immunopharma, Inc. (LYEL)
ARCH Venture Partners IX, LLC — 10% Owner
Shares
488,090
Price
$25.61
Total Value
$12.50M
Shares Held After
1,426,528
% of Holdings
34.2%
Xencor Inc (XNCR)
Dahiyat Bassil I — Director
Shares
6,606
Price
$11.02
Total Value
$72.80K
Shares Held After
546,316
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
Olian Judy D. — Director
Shares
200
Price
$510.00
Total Value
$102.00K
Shares Held After
4,645
% of Holdings
4.1%
Xencor Inc (XNCR)
Eckert Celia — SVP, GENERAL COUNSEL
Shares
1,767
Price
$11.02
Total Value
$19.47K
Shares Held After
76,918
% of Holdings
2.2%
Lyell Immunopharma, Inc. (LYEL)
ARCH Venture Fund XIII, L.P. — 10% Owner
Shares
488,090
Price
$25.61
Total Value
$12.50M
Shares Held After
1,426,528
% of Holdings
34.2%
Xencor Inc (XNCR)
Desjarlais John R — SR. VICE PRESIDENT & CSO
Shares
2,502
Price
$11.02
Total Value
$27.57K
Shares Held After
263,831
% of Holdings
0.9%
ARVINAS, INC. (ARVN)
Morrison Briggs — Director
Shares
20,000
Price
$13.40
Total Value
$268.07K
Shares Held After
96,021
% of Holdings
20.8%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
20,000
Price
$3.54
Total Value
$70.79K
Shares Held After
32,500
% of Holdings
61.5%
Altimmune, Inc. (ALT)
WEAVER GREGORY L — Chief Financial Officer
Shares
5,000
Price
$3.54
Total Value
$17.70K
Shares Held After
28,078
% of Holdings
17.8%
ADMA BIOLOGICS, INC. (ADMA)
ELMS STEVE — Director
Shares
7,000
Price
$15.39
Total Value
$107.73K
Shares Held After
2,045,730
% of Holdings
0.3%
Tectonic Therapeutic, Inc. (TECX)
Ruddy Marcella K. — Chief Medical Officer
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
69,747
% of Holdings
12.5%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
215
Price
$35.00
Total Value
$7.53K
Shares Held After
55,285
% of Holdings
0.4%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
6,047
Price
$30.00
Total Value
$181.41K
Shares Held After
55,500
% of Holdings
9.8%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
94,124
Price
$30.32
Total Value
$2.85M
Shares Held After
69,302
% of Holdings
57.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Dier Mardi — EVP and CFO
Shares
40
Price
$437.65
Total Value
$17.51K
Shares Held After
12,490
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Dier Mardi — EVP and CFO
Shares
80
Price
$436.69
Total Value
$34.94K
Shares Held After
12,530
% of Holdings
0.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Dier Mardi — EVP and CFO
Shares
80
Price
$435.31
Total Value
$34.83K
Shares Held After
12,610
% of Holdings
0.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Dier Mardi — EVP and CFO
Shares
160
Price
$434.20
Total Value
$69.47K
Shares Held After
12,690
% of Holdings
1.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Dier Mardi — EVP and CFO
Shares
116
Price
$432.56
Total Value
$50.18K
Shares Held After
12,850
% of Holdings
0.9%
Showing 551–600 of 3555 transactions (page 12 of 72)